INVO Bioscience, Inc.
INVO
$2.07
$0.239913.11%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.51% | 14.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.51% | 14.08% | |||
| Cost of Revenue | 1.34% | -4.13% | |||
| Gross Profit | 34.27% | 46.69% | |||
| SG&A Expenses | 83.78% | -22.38% | |||
| Depreciation & Amortization | 1.45% | 60.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 48.23% | -12.72% | |||
| Operating Income | -101.07% | 37.26% | |||
| Income Before Tax | -40.79% | 19.12% | |||
| Income Tax Expenses | -- | -92.17% | |||
| Earnings from Continuing Operations | -40.63% | 19.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.63% | 19.97% | |||
| EBIT | -101.07% | 37.26% | |||
| EBITDA | -132.50% | 47.37% | |||
| EPS Basic | -48.13% | 34.34% | |||
| Normalized Basic EPS | -110.57% | 46.15% | |||
| EPS Diluted | -48.10% | 34.36% | |||
| Normalized Diluted EPS | -110.57% | 46.15% | |||
| Average Basic Shares Outstanding | -5.05% | 21.88% | |||
| Average Diluted Shares Outstanding | -5.05% | 21.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
